Engelbrektsgatan 9-11
Stockholm
Sweden
46 8 34 71 10
https://medcap.se/en/
Sector(es): Healthcare
Industria: Medical Devices
Empleados a tiempo completo: 512
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Anders Dahlberg | Chief Executive Officer | 6.57M | N/D | 1976 |
Ms. Kristina Ekblad | Chief Financial Officer | N/D | N/D | 1974 |
Mr. Lars Ångman | Investment Manager | N/D | N/D | N/D |
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, and pharmaceuticals companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Northern Europe. It typically invests between SEK25 million ($2.75 million) and SEK150 million ($16.51 million) with enterprise value SEK50 million ($5.90 million) and SEK250 million ($23.06 million) and sales revenue between euro 5 million ($5.43 million) and euro 25 million ($27.18 million) and EBITDA between SEK1 million ($0.11 million) and SEK50 million ($5.50 million). The firm seeks to acquire stakes between 20% and 50% in its portfolio companies. It uses its capital and loans and makes balance sheet investments. MedCap AB (publ) was founded in 2001 and is based in Stockholm, Sweden with additional office in Solna, Sweden.
La calificación ISS Governance QuickScore de MedCap AB (publ) a partir del 1 de junio de 2024 es 4. Las puntuaciones principales son Auditoría: 6; Junta: 7; Derechos del accionista: 1; Compensación: 2.